Literature DB >> 15309045

Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

William R Perlman1, Cynthia Shannon Weickert, Mayada Akil, Joel E Kleinman.   

Abstract

Despite robust evidence for the heritability of schizophrenia, postmortem studies have not traditionally linked cellular and molecular neuropathology with underlying genetic mechanisms in this disorder. The completion of the first draft of the Human Genome Project and the use of novel strategies in studying complex genetic disorders including schizophrenia have led to the identification of a growing list of schizophrenia susceptibility genes. In this review, we describe the strategy used to incorporate 2 potential schizophrenia susceptibility genes in the postmortem investigation of the pathophysiology of schizophrenia driven by 2 well-established hypotheses, the dopamine hypothesis and the neurodevelopmental hypothesis. The first gene codes for catechol-O-methyltransferase, an enzyme involved in catecholamine degradation, and the second gene codes for brain-derived neurotrophic factor, a growth factor implicated in cell survival, synaptogenesis and the development of cortical pyramidal neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309045      PMCID: PMC446223     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  104 in total

1.  Association between the BDNF gene and schizophrenia.

Authors:  P Muglia; A M Vicente; M Verga; N King; F Macciardi; J L Kennedy
Journal:  Mol Psychiatry       Date:  2003-02       Impact factor: 15.992

2.  BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex.

Authors:  Maree J Webster; Cynthia Shannon Weickert; Mary M Herman; Joel E Kleinman
Journal:  Brain Res Dev Brain Res       Date:  2002-12-15

3.  A highly significant association between a COMT haplotype and schizophrenia.

Authors:  Sagiv Shifman; Michal Bronstein; Meira Sternfeld; Anne Pisanté-Shalom; Efrat Lev-Lehman; Avraham Weizman; Ilya Reznik; Baruch Spivak; Nimrod Grisaru; Leon Karp; Richard Schiffer; Moshe Kotler; Rael D Strous; Marnina Swartz-Vanetik; Haim Y Knobler; Eilat Shinar; Jacques S Beckmann; Benjamin Yakir; Neil Risch; Naomi B Zak; Ariel Darvasi
Journal:  Am J Hum Genet       Date:  2002-10-25       Impact factor: 11.025

4.  Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.

Authors:  Sherry Leonard; Judith Gault; Jan Hopkins; Judith Logel; Ruby Vianzon; Margaret Short; Carla Drebing; Ralph Berger; Diana Venn; Pinkhas Sirota; Gary Zerbe; Ann Olincy; Randal G Ross; Lawrence E Adler; Robert Freedman
Journal:  Arch Gen Psychiatry       Date:  2002-12

5.  Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.

Authors:  Robert M Bilder; Jan Volavka; Pál Czobor; Anil K Malhotra; James L Kennedy; Xingqun Ni; Robert S Goldman; Matthew J Hoptman; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Michal Kunz; Miranda Chakos; Thomas B Cooper; Jeffrey A Lieberman
Journal:  Biol Psychiatry       Date:  2002-10-01       Impact factor: 13.382

Review 6.  Genes for schizophrenia? Recent findings and their pathophysiological implications.

Authors:  Paul J Harrison; Michael J Owen
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

7.  Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.

Authors:  C S Weickert; T M Hyde; B K Lipska; M M Herman; D R Weinberger; J E Kleinman
Journal:  Mol Psychiatry       Date:  2003-06       Impact factor: 15.992

8.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

9.  Catechol-O-methyltransferase genotype and dopamine regulation in the human brain.

Authors:  Mayada Akil; Bhaskar S Kolachana; Debora A Rothmond; Thomas M Hyde; Daniel R Weinberger; Joel E Kleinman
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

10.  The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia.

Authors:  György Szekeres; Anna Juhász; Agnes Rimanóczy; Szabolcs Kéri; Zoltán Janka
Journal:  Schizophr Res       Date:  2003-12-01       Impact factor: 4.939

View more
  6 in total

1.  Neurobiology of severe mental disorders: from cell to bedside 25th International Symposium of the Centre de recherche en sciences neurologiques, Université de Montréal.

Authors:  Pierre-Paul Rompré; Emmanuel Stip; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2004-05       Impact factor: 6.186

Review 2.  Possible mechanisms of neurodegeneration in schizophrenia.

Authors:  Iván Pérez-Neri; Jesús Ramírez-Bermúdez; Sergio Montes; Camilo Ríos
Journal:  Neurochem Res       Date:  2006-09-28       Impact factor: 3.996

Review 3.  Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?

Authors:  S Bender; M Weisbrod; F Resch
Journal:  J Neural Transm (Vienna)       Date:  2007-05-21       Impact factor: 3.575

4.  Selection of reference gene expression in a schizophrenia brain cohort.

Authors:  Cynthia Shannon Weickert; Donna Sheedy; Debora A Rothmond; Irina Dedova; Samantha Fung; Therese Garrick; Jenny Wong; Antony J Harding; Sinthuja Sivagnanansundaram; Clare Hunt; Carlotta Duncan; Nina Sundqvist; Shan-Yuan Tsai; Jasna Anand; Daren Draganic; Clive Harper
Journal:  Aust N Z J Psychiatry       Date:  2010-01       Impact factor: 5.744

5.  Evidence for intact local connectivity but disrupted regional function in the occipital lobe in children and adolescents with schizophrenia.

Authors:  Tonya White; Steen Moeller; Marcus Schmidt; Jose V Pardo; Cheryl Olman
Journal:  Hum Brain Mapp       Date:  2011-06-14       Impact factor: 5.038

6.  The alkaloid alstonine: a review of its pharmacological properties.

Authors:  E Elisabetsky; L Costa-Campos
Journal:  Evid Based Complement Alternat Med       Date:  2006-01-16       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.